<DOC>
	<DOC>NCT01024348</DOC>
	<brief_summary>Extended-release tramadol is indicated for the management of moderate to severe pain in adults who require around-the-clock treatment. It provides an extended duration of action, more constant plasma concentrations, a reduced dosing frequency, and the potential for improved compliance and therapeutic outcomes. The present study was designed to evaluate the safety and effectiveness of this medication in the treatment of early postoperative pain after knee arthroscopy.</brief_summary>
	<brief_title>Safety and Effectiveness of Tramadex-OD After Knee Arthroscopy</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Men and nonpregnant women Age: 1865 years ASA classification I or II ambulatory knee arthroscopy under spinal anesthesia Pregnancy Intolerance to any opioid, tramadol or paracetamol spine surgery in the past renal or hepatic impairment cardiac or respiratory conditions that put the patient at risk for respiratory depression patients receiving: monoamine oxidase inhibitors, carbamazepine, quinidine, selective serotonin reuptake inhibitors or tricyclic antidepressants</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Surgery, knee arthroscopy</keyword>
	<keyword>Pain, postoperative</keyword>
	<keyword>tramadol, extended release</keyword>
</DOC>